General History
- Apr, 1950, Established as a research laboratory subordinated to a military pharmaceutical factory.
- 1951, the first drug in this lab--Anti-hookworm disease drug, Tetrachloroethylene was born.
- Jun, 1964, Chongqing Pharmaceutical Research Institute was founded.
- 1978, moved to company¡¯s present location on Tushan road.
- 1987, Ranitidine was successfully developed.
- 1989£¬Clindamycin was successfully developed, and then was successfully manufactured in our pilot workshop which afterwards was approved by FDA in 1994.
- 1950-2001, to be an important state-owned comprehensive research unit in national pharmaceutical sectors, and was one of the key industrial production bases of new drugs.
- Sep. 2001, CPRI, Co, Ltd was established through an agreement between FOSUN Pharmaceutical (Group), co, Ltd and Chongqing Chemical and Pharmaceutical Holding (Group) company, its majority shareholder is FOSUN Pharma.
History of cGMP manufacturing
- At the beginning of 1990s, CPRI began its cGMP manufacture course, and built up the workshop of Clindamycin HCl.
- In Aug., 1994, CPRI passed the FDA field inspection for Clindamycin HCl workshop.
- In 1995, CPRI was granted the certificate by TGA for Clindamycin HCl.
- In 1997, CPRI passed the FDA re-inspection for Clindamycin HCl workshop.
- In 2000, the workshop of Clindamycin HCl separated from CPRI, and set up Chongqing Carelife Pharmaceutical Co., Ltd.(CCPC)
 
As one of the shareholders, CPRI, as always, supports CCPC in an all-around ways.
- In Sept., 2001, CCPC passed the FDA re-inspection.
- In Apr., 2002, CCPC got the COS of Mitoxantrone HCl by EDQM.
- In May, 2002, Canada TPD visited CCPC and made a field inspection for Mitoxantrone HCl and finished dosage facility.
- In Aug., 2002, CCPC passed EDQM¡¯s field inspection for Clindamycin HCl.( It is EDQM¡¯s first field inspection in non-EU countries.)
- At the beginning of 2003, CCPC got the GMP certificates for bulk, minor volume injection, tablets, capsules and granules (Penicillin) by SFDA.
- In Mar., 2003, CCPC got the COS of Clindamycin HCl by EDQM.
- In recent years, CCPC has gained nineteen DMF numbers from the regulatory authorities of U.S., Canada, Europe, Brazil, etc.
 
At present
- Aug. 2004, CPRI built up the workshop of Iron Sucrose. Now the maximum capacity of Iron Sucrose reaches 13 tons per year.
- Dec. 2004, Iron Sucrose was approved by SFDA, the number of GMP certificate is Yu F0064.
- Jun,2005, we submitted iron sucrose DMF to FDA and we are ready for FDA inspection
- Now, CPRI can produce two APIs and some hard-to-find intermediates and sell them to all over the world. We are also planning to add new products into our portfolio.
|
Tel:8623-62513495
62505976 Fax:8623-62512066